MaaT’s FDA Woes Highlight Rocky Regulatory Path For Microbiome-Based Therapies

Clinical Hold Remains On Graft-Versus Host Disease Drug

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.